179 related articles for article (PubMed ID: 32167038)
1. Alternative observational designs to estimate the effectiveness of one dose of oral cholera vaccine in Lusaka, Zambia.
Ferreras E; Blake A; Chewe O; Mwaba J; Zulu G; Poncin M; Rakesh A; Page AL; Quilici ML; Azman AS; Cohuet S; Ciglenecki I; Malama K; Chizema-Kawesha E; Luquero FJ
Epidemiol Infect; 2020 Mar; 148():e78. PubMed ID: 32167038
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
[TBL] [Abstract][Full Text] [Related]
3. Delayed second dose of oral cholera vaccine administered before high-risk period for cholera transmission: Cholera control strategy in Lusaka, 2016.
Ferreras E; Matapo B; Chizema-Kawesha E; Chewe O; Mzyece H; Blake A; Moonde L; Zulu G; Poncin M; Sinyange N; Kasese-Chanda N; Phiri C; Malama K; Mukonka V; Cohuet S; Uzzeni F; Ciglenecki I; Danovaro-Holliday MC; Luquero FJ; Pezzoli L
PLoS One; 2019; 14(8):e0219040. PubMed ID: 31469853
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case-control study in Lusaka, Zambia.
Sialubanje C; Kapina M; Chewe O; Matapo BB; Ngomah AM; Gianetti B; Ngosa W; Kasonde M; Musonda K; Mulenga M; Michelo C; Sinyange N; Bobo P; Zyambo K; Mazyanga L; Bakyaita N; Mukonka VM
BMJ Open; 2022 Nov; 12(11):e066945. PubMed ID: 36368745
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia.
Tembo T; Simuyandi M; Chiyenu K; Sharma A; Chilyabanyama ON; Mbwili-Muleya C; Mazaba ML; Chilengi R
PLoS One; 2019; 14(5):e0215972. PubMed ID: 31150406
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
[TBL] [Abstract][Full Text] [Related]
8. Euvichol-plus vaccine campaign coverage during the 2017/2018 cholera outbreak in Lusaka district, Zambia: a cross-sectional descriptive study.
Mukonka VM; Sialubanje C; Matapo BB; Chewe O; Ngomah AM; Ngosa W; Hamoonga R; Sinyange N; Mzyece H; Mazyanga L; Bakyaita N; Kapata N
BMJ Open; 2023 Oct; 13(10):e070796. PubMed ID: 37798024
[TBL] [Abstract][Full Text] [Related]
9. "It depends how one understands it:" a qualitative study on differential uptake of oral cholera vaccine in three compounds in Lusaka, Zambia.
Heyerdahl LW; Pugliese-Garcia M; Nkwemu S; Tembo T; Mwamba C; Demolis R; Chilengi R; Gessner BD; Guillermet E; Sharma A
BMC Infect Dis; 2019 May; 19(1):421. PubMed ID: 31088376
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.
Azman AS; Parker LA; Rumunu J; Tadesse F; Grandesso F; Deng LL; Lino RL; Bior BK; Lasuba M; Page AL; Ontweka L; Llosa AE; Cohuet S; Pezzoli L; Sodjinou DV; Abubakar A; Debes AK; Mpairwe AM; Wamala JF; Jamet C; Lessler J; Sack DA; Quilici ML; Ciglenecki I; Luquero FJ
Lancet Glob Health; 2016 Nov; 4(11):e856-e863. PubMed ID: 27765293
[TBL] [Abstract][Full Text] [Related]
12. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design.
Franke MF; Jerome JG; Matias WR; Ternier R; Hilaire IJ; Harris JB; Ivers LC
Vaccine; 2017 Oct; 35(43):5819-5827. PubMed ID: 28916247
[TBL] [Abstract][Full Text] [Related]
14. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh.
Khan AI; Islam MS; Islam MT; Ahmed A; Chowdhury MI; Chowdhury F; Siddik MAU; Clemens JD; Qadri F
Vaccine; 2019 Feb; 37(6):827-832. PubMed ID: 30639459
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia.
Teshome S; Desai S; Kim JH; Belay D; Mogasale V
Hum Vaccin Immunother; 2018; 14(10):2427-2433. PubMed ID: 29648523
[TBL] [Abstract][Full Text] [Related]
16. Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage.
Parker LA; Rumunu J; Jamet C; Kenyi Y; Lino RL; Wamala JF; Mpairwe AM; Muller V; Llosa AE; Uzzeni F; Luquero FJ; Ciglenecki I; Azman AS
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005652. PubMed ID: 28594891
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
[TBL] [Abstract][Full Text] [Related]
18. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
[No Abstract] [Full Text] [Related]
19. Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.
Poncin M; Zulu G; Voute C; Ferreras E; Muleya CM; Malama K; Pezzoli L; Mufunda J; Robert H; Uzzeni F; Luquero FJ; Chizema E; Ciglenecki I
Bull World Health Organ; 2018 Feb; 96(2):86-93. PubMed ID: 29403111
[TBL] [Abstract][Full Text] [Related]
20. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial.
Ali M; Debes AK; Luquero FJ; Kim DR; Park JY; Digilio L; Manna B; Kanungo S; Dutta S; Sur D; Bhattacharya SK; Sack DA
PLoS Med; 2016 Sep; 13(9):e1002120. PubMed ID: 27622507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
